Eisai Co Ltd (4523.T) stock: key figures, P/E, revenue and dividend

Health Care · Japan · ISIN JP3160400002

Price
4,921.00 JPY
Market cap
1.39 tn JPY
P/E (2026)
35.98
P/S (2026)
1.68
Dividend yield
3.25 %
Net margin
4.67 %
Return on equity (ROE)
4.17 %
Return on assets (ROA)
2.66 %

Eisai Co Ltd financials

Fiscal year20252026
Revenue789.40 bn JPY825.38 bn JPY
Gross profit597.23 bn JPY634.16 bn JPY
EBIT49.24 bn JPY40.21 bn JPY
Net income46.43 bn JPY38.56 bn JPY
Diluted EPS – continuing operations164.59 JPY136.78 JPY

Full history since 1994, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Eisai Co Ltd

Eisai Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals in Japan. The company operates through pharmaceuticals business and other business segments. It offers Lenvima, a multi-kinase inhibitor which is involved in tumor angiogenesis or tumor malignancy; LEQEMBI, a humanized IgG1 monoclonal antibody against amyloid-beta (Aß) protofibrils; and Dayvigo, a novel small molecule compound. The company also provides prescription drugs; and over-the-counter drugs, as well as focuses on neurology and oncology, and other therapeutic areas. It operates in Europe, the Middle East, Africa, Russia, Oceania, the Americas, China, East Asia, the Global South, and internationally. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 19.10.2026. Details in the risk notice.

Eisai Co Ltd stock (4523.T): P/E, revenue, dividend | finmetric